Who is Going to Pay for Psychedelic Therapies?
Wednesday
|
Location: Zoom 1.00 General CLE Credit Available This panel will explore how psychedelic advocates, drug developers, private insurers, government programs, and individual patients will share the financial burden, and what models might work best to create equitable access for these therapies. Attendees will gain insight into the financial levers and regulatory changes required to make psychedelic medicine accessible for everyone. |
The Impact of Prosecution Length on Patent Litigation Outcomes
Tuesday
|
Location: Zoom 1.25 General CLE Credit Available This panel will explore findings from a recent comprehensive study that examined correlations between the thoroughness of examination by the USPTO and subsequent patent litigation outcomes. Analyzing over 89,000 patents litigated since March 2000, the study assessed how the number of rejections a patent receives affects its likelihood of invalidity, infringement, and unenforceability in court. The surprising results from this research may offer strategies for patent owners to refine their prosecution and litigation practices. |